About Paragon Genomics
Paragon Genomics is a Healthcare company based in San Francisco (United States) founded in 2015. Provider of technologies and solutions genomic research and precision medicine. Paragon Genomics has raised $8 million across 1 funding round from investors including Geintech Technologies, Wisemont Capital and Co-win Ventures. The company has 26 employees. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is PARAGON GENOMICS, INC. Its competitors include RareCyte, Sequenta and seqWell; 3 of its 3 listed competitors have raised funding.
Company details
Paragon Genomics was founded in 2015 and is headquartered in San Francisco, United States. Patented targeted sequencing technologies, including CleanPlex DNA, CleanPlex RNA, CleanPlex UMI, and OmniFusion, are developed by the company. Comprehensive solutions are offered in the genomics sector for applications such as precision oncology, infectious disease testing, inherited disease testing, single-cell analysis, and molecular breeding. Operations focus on advancing research and precision medicine worldwide.
- Headquarters San Francisco, United States
- Employees 26
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website paragongenomics.com
- Social LinkedIn X Facebook
- Legal Name Paragon Genomics, Inc.
- Total Equity Funding$8M (USD)
in 1 rounds
- Latest Funding Round$8M (USD), Series A
Sep 2017
- InvestorsGeintech Technologies
& 4 more
- Employee Count26
Funding Insights of Paragon Genomics
Paragon Genomics has successfully raised a total of $8M through 1 strategic funding round. The most recent funding activity was a Series A round of $8 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8M
- Total Rounds 1
- Last Round Series A — $8M
- First Round $8M
(Sep 2017)
- Investors Count 5
All 1 funding rounds of Paragon Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2017 | $8M | Series A | – | Co-win Ventures, Fosun·Star Future Capital |
5 investors in total: 5 institutional.
Investors in Paragon Genomics
Paragon Genomics has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Geintech Technologies, Wisemont Capital and Co-win Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Geintech Technologies is engaged in manufacturing high-standard communication cables. | hedaventures.com | Corona, United States | ||
US focused seed & early stage VC firm | wisemontcapital.com | Belmont, United States | ||
VC fund investing in startups | cowinvc.com | Suzhou, China | ||
Cloudstone Capital is engaged in venture capital investments focusing on healthtech. | 2016 | cloudstonevc.com | Redwood City, United States | |
| fosunventure.com |
Investor details for Paragon Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Paragon Genomics
12 people are tracked at Paragon Genomics (4 in leadership, 5 in board & advisors, 3 in team); the tracked headcount is 26.
| Name | Role | Group |
|---|---|---|
Zhitong Liu | Co-Founder & CTO | Leadership |
Bruce Simmons | VP & Sales Manager | Leadership |
Yutao Fu | Director, Bioinformatics | Leadership |
Tao Chen | Co-Founder & CEO | Leadership |
Rodney Turner | Advisor | Board & advisors |
Gary Zweiger | Advisor | Board & advisors |
Wayne Tam | Advisor | Board & advisors |
Joe Keegan | Advisor | Board & advisors |
Jin Billy Li | Advisor | Board & advisors |
Ryan Forgione | NGS Sales Specialist | Team |
Vidushi Kapoor | Staff Bioinformatics Scientist | Team |
Niyati Thosani | Sr. Manager, Technical Operations And Support | Team |
Complete people profiles for Paragon Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Paragon Genomics
2 dated milestones of Paragon Genomics across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Paragon Genomics is founded.
- Funding First funding round of $8.0M.
Competitors of Paragon Genomics
Paragon Genomics has 3 listed competitors in our database, 3 of them funded. They include RareCyte, Sequenta and seqWell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| sequenta.com | 2008 | San Francisco, United States | $43.46M | 58 | Immuno-sequencing products are developed for disease diagnostics and treatment. | |
| seqwell.com | 2014 | Beverly, United States | $24.51M | 30 | NGS-based reagents and kits are supplied for life sciences research. |
Detailed competitors of Paragon Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Paragon Genomics
The website of Paragon Genomics (paragongenomics.com) receives about 6.2K visits a month.
- Monthly visits6.2K
▲ 8% vs previous month
Websites whose visitors overlap most with Paragon Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| idtdna.com | 100% | 505.8K | #85,096 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Paragon Genomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Paragon Genomics
Complete news archive for Paragon Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragon Genomics
Paragon Genomics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Paragon Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Paragon Genomics is a funded company, having raised a total of $8M across 1 funding round to date. The company's 1st funding round was a Series A of $8M, raised on Sep 2017.
Paragon Genomics has 26 employees.
Paragon Genomics was founded in 2015 and is headquartered in San Francisco, United States. Patented targeted sequencing technologies, including CleanPlex DNA, CleanPlex RNA, CleanPlex UMI, and OmniFusion, are developed by the company. Comprehensive solutions are offered in the genomics sector for applications such as precision oncology, infectious disease testing, inherited disease testing, single-cell analysis, and molecular breeding. Operations focus on advancing research and precision medicine worldwide.
Paragon Genomics has 5 investors. Key investors include Geintech Technologies, Wisemont Capital, Co-win Ventures, Cloudstone Capital, and Fosun·Star Future Capital.
Paragon Genomics operates through Paragon Genomics, Inc..